Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles)

Minimum order is 5 pieces!Оригинальный текст производителя/источника приведён ниже. Он может содержать сведения о рынке источника и не отражает условия продажи в России.Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) is a dermal filler from Avalon, listed for registered Australian clinics in our Dermal Filler range. Pack: 1 syringe x 1 ml + 2 needles. Priced in AUD (A$83.00). Sydney dispatch, nationwide. Not a public treatment clinic.
About Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles)
AVALON Fine
AVALON™ Fine is a non-surgical filler which contains highly-purified hyaluronic acid (20 mg/ml).
AVALON™ Fine is designed to be injected into the superficial dermis for the correction of fine wrinkles and facial lines.
AVALON™ Fine offers an optimal combination of viscosity and elasticity and is made from a non-animal origin stabilised hyaluronic acid. An ideal solution for the correction of thin dermal wrinkles with results lasting up to 9 months.*
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Benefits

Developed with MCO™ Tech. purification technology
Easy correction of thin dermal wrinkles
Absolutely safe for use in the face and body
No edema or inflammations
Deep moisturising of the skin
Normalisation of body fluids
Improvement of complexion
Suitable for patients with sensitive skin
No migration and no lumps

Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute. The cross-linking agent serves to connect hyaluronic acid chains to form a net. Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
Indications

Thin dermal wrinkles (Class I-II)
Perioral wrinkles
Volume loss in temporal, forehead and glabellar areas
“Crow’s feet“ wrinkles
Horizontal neck wrinkles
Nasolacrimal and palpebromalar lines
Аtrophic scars

AVALON Fine Plus

AVALON™ Fine Plus is a non-surgical filler which contains highly-purified hyaluronic acid (20 mg/ml) and lidocaine (0.3%) for anaesthetic effects.

AVALON™ Fine Plus is designed to be injected into the superficial dermis for the correction of fine wrinkles and facial lines. The presence of lidocaine is intended to reduce patient discomfort during treatment.
An ideal solution for the correction of the finest and thinnest wrinkles with results lasting up to 9 months.*
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Benefits

Developed with MCO™ Tech. purification technology
Painless and safe procedure
Long lasting effect
Short recovery period
Contains an anaesthetic
Optimal concentration of HA
Even distribution of product under the skin

Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimizing Cross-linking-agent by Optimizing reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimization of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimized, thereby maximizing the efficiency of the cross-linking reaction.
Indications

Thin dermal wrinkles (Class I-II)
Perioral wrinkles
Volume loss in temporal region
Horizontal neck wrinkles
Loss of volume in lips
Atrophic scars
Nasolacrimal and palpebromalar lines
Wrinkles on the back of the hands

AVALON Vital
AVALON Vital is a non-surgical filler containing highly purified hyaluronic acid (20 mg/ml).
It is designed to act on the skin to treat wrinkles and enlarge the lips.
AVALON Vital offers an optimal combination of viscosity and elasticity and is made from stabilized hyaluronic acid of non-animal origin.
The ideal solution for the correction of fine lines and wrinkles with an effect that lasts from 12 to 18 months*.
* The duration of the effect may vary depending on the characteristics of the patient, the injection method and the type of procedure.
Benefits
Developed with MCO™ technology Easy correction of moderate wrinkles Absolutely safe use on the face and body. No swelling or inflammation Deep hydration of the skin Normalization of body fluids Suitable for patients with sensitive skin No accounting and no lumps Cross-linked hyaluronic acid in AVALON™ fillers
MCO™ technology . (Minimizing the crosslinking agent by using reaction technology) is a technology developed by Koru Pharmaceuticals Research Institute.
The crosslinking agent is used to connect the hyaluronic acid chains in a network.
Due to the specific conditions of the crosslinking reaction, when a chemical reaction occurs between the crosslinking agent and the HA, the use of the crosslinking agent is minimized, thus maximizing the effectiveness of the crosslinking reaction.
Indications
Medium wrinkles and folds Marionette wrinkles Mouth frown Wrinkles on the back of the hand Minor aesthetic defects on earlobes Loss of soft tissue and viscous tissue
AVALON Vital Plus
AVALON™ Vital Plus is a non-surgical filler contains highly-purified hyaluronic acid (20 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
AVALON™ Vital Plus is designed to be injected into the dermis for the treatment of mid-depth wrinkles and lip augmentation. The presence of lidocaine is intended to reduce patient discomfort during treatment.
The mid-viscosity filler, AVALON™ Vital Plus is an ideal solution for the correction of the significant wrinkles with results lasting from 9 – 12 months*.
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Benefits

Developed with MCO™ Tech. purification technology
Painless and safe procedure
Long lasting effect
Short recovery period
Contains an anaesthetic
Optimal concentration of HA
Even distribution of product under the skin

Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
Indications

Wrinkles of mid-depth (nasolabial & labial folds)
Marionette folds and mouth frown
Visible loss of volume in the lips
Visible wrinkles on the back of the hands
Aesthetic defects on ear lobes
Volumetric lip correction

AVALON Grand Plus
AVALON™ Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.
The viscous filler, AVALON™ Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 – 18 months*.
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
Benefits

Developed with MCO™ Tech. purification technology
Painless and safe procedure
Long lasting effect
Short recovery period
Contains an anaesthetic
Optimal concentration of HA
Even distribution of product under the skin
Correction of moderate to severe facial wrinkles and folds
Restoring volume and contouring of the face shape

Indications

Deep wrinkles
Aesthetic defects in buccal, zygomatic, mandibular and nasal areas
Volume loss in the zygomatic and nasal areas
Undefined facial contours

AVALON Ultra Plus
AVALON™ Ultra Plus is a non-surgical filler contains highly-purified hyaluronic acid (20 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
It is designed to be injected into the dermis for the treatment of deep wrinkles and folds, volume restoration in cheeks, and chin augmentation.
AVALON™ Ultra Plus offers an optimal combination of viscosity and elasticity and is made from a non-animal origin stabilised hyaluronic acid. An ideal solution for the intensive filling of deep wrinkles and restoring volume with results lasting from 9 – 12 months*.
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Benefits

Developed with MCO™ Tech. purification technology
Easy correction of deep wrinkles
Absolutely safe for use in the face and body
No edema or inflammations
Deep moisturising of the skin
Normalisation of body fluids
Improvement of complexion
Suitable for patients with sensitive skin

Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
Indications

Deep wrinkles and folds (Class IV-V )
Volume loss in soft tissue
Undefined facial contours
Volume loss in the temporal, zygomatic and nasal areas
Aesthetic defects in cheeks and chin areas, correction of mandibular angle

Minimum order is 5 pieces!
Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) — key details for ordering

Product: Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles)
Brand: Avalon
Category: Dermal Filler
Pack format: 1 syringe x 1 ml + 2 needles
Price: A$83.00 AUD, including GST where applicable
Dispatch: Sydney, Australia-wide

Using Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) in clinic practice
Check the gel thickness, lidocaine content and syringe count on this page against your usual protocol before ordering. Store unopened boxes as the manufacturer directs, do not use after the expiry printed on the pack, and work from the manufacturer instructions and your own training for injection depth and technique.
Ordering Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) and related products
Compare Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) with Crystal Lite/Deep/Ultra filler, Liporase Fillers dissolver filler dissolver, AestheFill (200mg.) Facial Wrinkle Filler, or browse the full Dermal Filler catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles) is covered in the reference article on Hyaluronic acid, and Australian practitioners should confirm regulatory positionings with the TGA before use.Реализация профессиональной продукции осуществляется в соответствии с законодательством РФ. Регистрационные документы предоставляются по запросу. Информация не является публичной офертой.